Event
JAPAC | Keeping Pace with RWE: What Do Regulators, Payers, and Patients Want?
calendar

April 10, 2025

Calendar
clock

2:00pm - 4:30pm

(GMT+08:00)

Register

View all IQVIA events

Explore the impact of Real World Evidence (RWE) on healthcare decision-making among regulators, payers, and patients throughout the Asia-Pacific region. With emerging AI applications, evolving reimbursement policies, and new strategies in rare disease research, pharmaceutical companies must adapt to leverage RWE effectively. This virtual conference will explore key developments and best practices to integrate RWE into decision-making across diverse healthcare landscapes.

Our upcoming virtual conference explores new opportunities to harness RWE and:
  • Uncover AI-driven RWE use cases for Medical Affairs in Asia-Pacific
  • Explore patient-centered research, especially in rare diseases
  • Gain insights into multi-country database studies across APAC and globally
  • Examine Taiwan’s new RWE-focused reimbursement policies
  • Review Japan’s approach to drug access and the role of external comparators

Related solutions

Contact Us